- Home
- DCTH vs AEYE Comparison
DCTH vs AEYE Comparison
Compare DCTH & AEYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- AEYE
- Stock Information
- Founded
- DCTH 1988
- AEYE 2005
- Country
- DCTH United States
- AEYE United States
- Employees
- DCTH N/A
- AEYE N/A
- Industry
- DCTH Medical/Dental Instruments
- AEYE Computer Software: Prepackaged Software
- Sector
- DCTH Health Care
- AEYE Technology
- Exchange
- DCTH Nasdaq
- AEYE Nasdaq
- Market Cap
- DCTH 485.5M
- AEYE 138.0M
- IPO Year
- DCTH N/A
- AEYE N/A
- Fundamental
- Price
- DCTH $12.69
- AEYE $12.19
- Analyst Decision
- DCTH Strong Buy
- AEYE Strong Buy
- Analyst Count
- DCTH 4
- AEYE 5
- Target Price
- DCTH $24.00
- AEYE $26.40
- AVG Volume (30 Days)
- DCTH 777.8K
- AEYE 69.0K
- Earning Date
- DCTH 08-04-2025
- AEYE 07-24-2025
- Dividend Yield
- DCTH N/A
- AEYE N/A
- EPS Growth
- DCTH N/A
- AEYE N/A
- EPS
- DCTH N/A
- AEYE N/A
- Revenue
- DCTH $53,850,000.00
- AEYE $36,851,000.00
- Revenue This Year
- DCTH $155.42
- AEYE $20.16
- Revenue Next Year
- DCTH $37.93
- AEYE $18.74
- P/E Ratio
- DCTH N/A
- AEYE N/A
- Revenue Growth
- DCTH 1068.87
- AEYE 16.52
- 52 Week Low
- DCTH $7.17
- AEYE $8.91
- 52 Week High
- DCTH $18.23
- AEYE $34.85
- Technical
- Relative Strength Index (RSI)
- DCTH 33.81
- AEYE 49.88
- Support Level
- DCTH $13.30
- AEYE $11.43
- Resistance Level
- DCTH $14.15
- AEYE $12.17
- Average True Range (ATR)
- DCTH 0.64
- AEYE 0.55
- MACD
- DCTH -0.26
- AEYE 0.01
- Stochastic Oscillator
- DCTH 8.28
- AEYE 53.23
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About AEYE AudioEye Inc.
AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. Trusted by the ADP, Tommy Hilfiger, A360 Media, Samsung, Landry's and others. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences.